Searchable abstracts of presentations at key conferences in endocrinology

ea0085p36 | Obesity 1 | BSPED2022

Percentage excess weight and risk of co-morbidity in obese children

van Boxel Elizabeth , Lokulo-Sodipe Oluwakemi , Jayne Kathryn , Davis Nikki

Background: One in four children in England are now obese by school year 6. Childhood obesity is associated with significant co-morbidity including type 2 diabetes (T2DM), non-alcoholic fatty liver disease (NAFLD), obstructive sleep apnoea (OSA) and depression. NICE guidance suggests consideration of co-morbidity screening in children with body mass index (BMI) >98th centile but BMI does not accurately reflect adiposity in children owing to confounding effects of gender, h...

ea0085p76 | Obesity 2 | BSPED2022

Semaglutide as a safe and effective weight loss treatment in children with obesity

van Boxel Elizabeth , Boulos Nabil , Jayne Kathryn , Reilly Joseph , Mayes Rebecca , Davis Nikki

Background: A quarter of UK children now leave primary school obese. Childhood obesity is associated with significant comorbidity including obstructive sleep apnoea, type 2 diabetes, non-alcoholic fatty liver disease, hypertension and depression. We report our experience of using semaglutide, a weekly subcutaneous GLP1 receptor agonist, as a weight-loss adjunct for severely obese children in combination with dietary and lifestyle support from a multidisciplinary team.<p cl...